Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities
The molecular pathogenesis of hematological diseases is often driven by genetic and epigenetic alterations. Next-generation sequencing has considerably increased our genomic knowledge of these disorders becoming ever more widespread in clinical practice. In 2012 Oxford Nanopore Technologies (ONT) re...
Main Authors: | Crescenzio Francesco Minervini, Cosimo Cumbo, Paola Orsini, Luisa Anelli, Antonella Zagaria, Giorgina Specchia, Francesco Albano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.00076/full |
Similar Items
-
Third-Generation Sequencing in Clinical Practice: The New Era of Precision Medicine?
by: Cosimo Cumbo, et al.
Published: (2022-06-01) -
Modification mapping by nanopore sequencing
by: Laura K. White, et al.
Published: (2022-10-01) -
Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers
by: Luisa Anelli, et al.
Published: (2021-07-01) -
Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies
by: Nicoletta Coccaro, et al.
Published: (2020-04-01) -
Nanopore-Based Detection of Viral RNA Modifications
by: Jonathan S. Abebe, et al.
Published: (2022-06-01)